Fundz

SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer

PUBLIC · SGPJan 06, 2026

Position

Chief Financial Officer

Company

SpyGlass Pharma, Inc.

Jean-Frédéric Viret
Aliso ViejoBiotechnologyHealthcareHealth Care

Description

SpyGlass Pharma has announced the appointment of Jean-Frédéric Viret, Ph.D., as the company's Chief Financial Officer. Dr. Viret joins with over twenty years of experience in corporate finance within the life sciences sector.

Quick answer

SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer (January 6, 2026). SpyGlass Pharma, Inc. is based in Aliso Viejo, California, United States.

Who is the new Chief Financial Officer at SpyGlass Pharma, Inc?
SpyGlass Pharma, Inc. named Jean-Frédéric Viret Chief Financial Officer, announced January 6, 2026.
What did SpyGlass Pharma, Inc. announce on January 6, 2026?
SpyGlass Pharma has announced the appointment of Jean-Frédéric Viret, Ph.D., as the company's Chief Financial Officer. Dr. Viret joins with over twenty years of experience in corporate finance within the life sciences sector.
What does SpyGlass Pharma, Inc. do?
SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman.
Where is SpyGlass Pharma, Inc. based?
SpyGlass Pharma, Inc. is based in Aliso Viejo, California, United States.
Which similar companies made leadership changes around the same time?
Damora Therapeutics, Inc. (January 6, 2026), Fractyl Health (January 6, 2026), Beyond Air (December 30, 2025) and Interwell Health (January 26, 2026) also announced leadership changes within 45 days of SpyGlass Pharma, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at SpyGlass Pharma, Inc., and when

A new leader at SpyGlass Pharma, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day SpyGlass Pharma, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SpyGlass Pharma, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SpyGlass Pharma, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SpyGlass Pharma, Inc.

Location

27061 Aliso Creek Road

Aliso Viejo, California, United States

About

SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases based on technology originally developed in the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SpyGlass Pharma, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Rachel
Senior decision-maker at this company
••••••••@••••••••

See Rachel's verified email →

Glenn
Senior decision-maker at this company
••••••••@••••••••

See Glenn's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for SpyGlass Pharma, Inc.'s next move

Learn about Strategic plan

SpyGlass Pharma, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.